| Contraceptive hormone use and cardiovascular disease CL Shufelt, CN Bairey Merz Journal of the American College of Cardiology 53 (3), 221-231, 2009 | 384 | 2009 |
| Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction: a National Heart, Lung, and Blood Institute-sponsored … LEJ Thomson, J Wei, M Agarwal, A Haft-Baradaran, C Shufelt, PK Mehta, ... Circulation: Cardiovascular Imaging 8 (4), e002481, 2015 | 245 | 2015 |
| Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease PK Mehta, P Goykhman, LEJ Thomson, C Shufelt, J Wei, YC Yang, E Gill, ... JACC: Cardiovascular Imaging 4 (5), 514-522, 2011 | 223 | 2011 |
| Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study J Wei, PK Mehta, BD Johnson, B Samuels, S Kar, RD Anderson, ... JACC: Cardiovascular Interventions 5 (6), 646-653, 2012 | 217 | 2012 |
| A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve CN Bairey Merz, EM Handberg, CL Shufelt, PK Mehta, MB Minissian, ... European heart journal 37 (19), 1504-1513, 2016 | 195 | 2016 |
| Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus ML Ishimori, R Martin, DS Berman, P Goykhman, LJ Shaw, C Shufelt, ... JACC: Cardiovascular Imaging 4 (1), 27-33, 2011 | 183 | 2011 |
| Sex hormones and the QT interval: a review T Sedlak, C Shufelt, C Iribarren, CNB Merz Journal of women's health 21 (9), 933-941, 2012 | 163 | 2012 |
| Sex-specific physiology and cardiovascular disease CL Shufelt, C Pacheco, MS Tweet, VM Miller Sex-Specific Analysis of Cardiovascular Function, 433-454, 2018 | 156 | 2018 |
| Hypothalamic amenorrhea and the long-term health consequences CL Shufelt, T Torbati, E Dutra Seminars in reproductive medicine 35 (03), 256-262, 2017 | 154 | 2017 |
| DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health—National Heart, Lung, and Blood Institute (NHLBI … C Shufelt, P Bretsky, CM Almeida, BD Johnson, LJ Shaw, R Azziz, ... The Journal of Clinical Endocrinology & Metabolism 95 (11), 4985-4992, 2010 | 150 | 2010 |
| Pregnancy and reproductive risk factors for cardiovascular disease in women AC O’Kelly, ED Michos, CL Shufelt, JV Vermunt, MB Minissian, ... Circulation research 130 (4), 652-672, 2022 | 143 | 2022 |
| Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women’s Health Initiative Observational Study CL Shufelt, CNB Merz, RL Prentice, MB Pettinger, JE Rossouw, VR Aroda, ... Menopause 21 (3), 260-266, 2014 | 130 | 2014 |
| Maternal recall of hypertensive disorders in pregnancy: a systematic review JJ Stuart, CN Bairey Merz, SL Berga, VM Miller, P Ouyang, CL Shufelt, ... Journal of women's health 22 (1), 37-47, 2013 | 114 | 2013 |
| Persistent chest pain and no obstructive coronary artery disease A Phan, C Shufelt, CNB Merz Jama 301 (14), 1468-1474, 2009 | 107 | 2009 |
| Diastolic dysfunction: improved understanding using emerging imaging techniques D Daneshvar, J Wei, K Tolstrup, LEJ Thomson, C Shufelt, CNB Merz American heart journal 160 (3), 394-404, 2010 | 102 | 2010 |
| The 2022 hormone therapy position statement of the North American Menopause Society SS Faubion, CJ Crandall, L Davis, SR El Khoudary, HN Hodis, RA Lobo, ... Menopause 29 (7), 767-794, 2022 | 100 | 2022 |
| Preeclampsia and vascular function: a window to future cardiovascular disease risk D Enkhmaa, D Wall, PK Mehta, JJ Stuart, JW Rich-Edwards, CNB Merz, ... Journal of Women's Health 25 (3), 284-291, 2016 | 84 | 2016 |
| Safety of testosterone use in women CL Shufelt, GD Braunstein Maturitas 63 (1), 63-66, 2009 | 79 | 2009 |
| Age at menarche and risk of cardiovascular disease outcomes: findings from the National Heart Lung and Blood Institute‐sponsored Women's Ischemia Syndrome Evaluation JJ Lee, G Cook‐Wiens, BD Johnson, GD Braunstein, SL Berga, ... Journal of the American Heart Association 8 (12), e012406, 2019 | 75 | 2019 |
| Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE) RC Thurston, BD Johnson, CL Shufelt, GD Braunstein, SL Berga, ... Menopause 24 (2), 126-132, 2017 | 72 | 2017 |
C. Noel Bairey MerzCedars-Sinai Medical CenterVerified email at cshs.org
